HealthIndustrialUAIF I

PulseMedica is pioneering ophthalmic laser surgery by developing the first purpose-designed, 3D image-guided femtosecond laser system to treat eye floaters.

Problem

Eye floaters represent a substantial unmet need, affecting over 50% of adults; out of which 40% with moderate to severe symptoms interfere with reading, concentration, and daily life. There is currently no FDA-approved, non-surgical treatment specifically for eye floaters, leaving patients with limited options, including observation, invasive vitrectomy, or off-label YAG laser vitreolysis.

Solution

PulseMedica is developing an automated, high-precision, image-guided laser platform designed for safe, non-invasive treatment of eye floaters. The system combines AI-powered floater identification and tracking, 3D volumetric imaging, and femtosecond laser delivery to enable precise, physician-supervised treatment in an office-based setting, with potential future applications across vitreoretinal disease.

Features include:

  • AI-powered floater identification and tracking;
  • High-resolution 3D multimodal imaging and volumetric capture;
  • Real-time eye tracking and stabilization;
  • Automated, high-precision laser targeting;
  • Image-guided femtosecond laser treatment;
  • Physician-supervised treatment with integrated safety systems

 

Traction

  • Completed human floater-imaging study on 250 eyes;
  • Completed preclinical laser-safety studies and obtained SPE-3000 system safety certification;
  • Raised over $25 million in funding;
  • Established global portfolio of 65+ patent assets, 12 U.S. patents issued/allowed.

Business model

LASIK-like: B2B medical-device system sales, annual service, and per-procedure consumables and laser fees.

Founders
Nir Katchinskiy
Founded

2018

Invested

2024

Status

Active